Sylvia Cheung
Direttore Finanziario/CFO presso OCULIS HOLDING AG
Patrimonio netto: 798 356 $ in data 30/04/2024
Posizioni attive di Sylvia Cheung
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| OCULIS HOLDING AG | Direttore Finanziario/CFO | 01/09/2020 | - |
| Public Communications Contact | 01/09/2020 | - |
Storia della carriera di Sylvia Cheung
Precedenti posizioni note di Sylvia Cheung
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| ANIKA THERAPEUTICS, INC. | Comptroller/Controller/Auditor | 01/10/2005 | 10/08/2020 |
| Direttore Finanziario/CFO | 01/04/2013 | 10/08/2020 | |
| Contatto Relazioni con gli Investitori | 01/10/2005 | 10/08/2020 | |
| Segretario Aziendale | 01/04/2013 | 04/03/2020 | |
| Treasurer | 01/04/2013 | 10/08/2020 | |
Transkaryotic Therapies, Inc.
 Transkaryotic Therapies, Inc. Miscellaneous Commercial ServicesCommercial Services Transkaryotic Therapies, Inc. (TKT) was a biopharmaceutical company with a major focus on developing products for the treatment of rare diseases. The company is used to markets one product, Replagal™, for the treatment of Fabry disease in the European Union and other countries, and was developing products for Hunter syndrome and Gaucher disease. The company was located in Cambridge, MA. | Corporate Officer/Principal | 01/01/2000 | - |
PricewaterhouseCoopers LLP
 PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services PricewaterhouseCoopers LLC provides assurance, tax and advisory services. Its services include audit and assurance, consulting, deals, human resources, legal, tax, and family business. The firm also offers accountability, risk management, structuring, mergers and acquisitions, and performance and process improvement. The company was founded in 1998 and is headquartered in Buffalo, NY. | Corporate Officer/Principal | 01/01/1995 | 01/01/2000 |
Formazione di Sylvia Cheung
| University of Massachusetts | Undergraduate Degree |
| Boston University | Masters Business Admin |
Statistiche
Distribuzione geografica
| Stati Uniti | 4 |
| Canada | 2 |
| Israele | 2 |
Posizioni
| Corporate Officer/Principal | 3 |
| Director of Finance/CFO | 2 |
| Comptroller/Controller/Auditor | 1 |
Settori
| Health Technology | 3 |
| Commercial Services | 3 |
| Consumer Services | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| ANIKA THERAPEUTICS, INC. | Health Technology |
| OCULIS HOLDING AG | Health Technology |
| Aziende private | 2 |
|---|---|
Transkaryotic Therapies, Inc.
Transkaryotic Therapies, Inc. Miscellaneous Commercial ServicesCommercial Services Transkaryotic Therapies, Inc. (TKT) was a biopharmaceutical company with a major focus on developing products for the treatment of rare diseases. The company is used to markets one product, Replagal™, for the treatment of Fabry disease in the European Union and other countries, and was developing products for Hunter syndrome and Gaucher disease. The company was located in Cambridge, MA. | Commercial Services |
PricewaterhouseCoopers LLP
PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services PricewaterhouseCoopers LLC provides assurance, tax and advisory services. Its services include audit and assurance, consulting, deals, human resources, legal, tax, and family business. The firm also offers accountability, risk management, structuring, mergers and acquisitions, and performance and process improvement. The company was founded in 1998 and is headquartered in Buffalo, NY. | Commercial Services |
- Borsa valori
- Insiders
- Sylvia Cheung
- Esperienza